|
[1]
|
Amin, M., Edge, S. and Greene, F. (2017) AJCC Cancer Staging Manual. Springer International Publishing.
|
|
[2]
|
Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Klein, A.P. (2021) Pancreatic Cancer Epidemiology: Understanding the Role of Lifestyle and Inherited Risk Factors. Nature Reviews Gastroenterology & Hepatology, 18, 493-502. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Gencer, B., Kronenberg, F., Stroes, E.S. and Mach, F. (2017) Lipoprotein(a): The Revenant. European Heart Journal, 38, 1553-1560. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Jiang, J., Nilsson-Ehle, P. and Xu, N. (2006) Influence of Liver Cancer on Lipid and Lipoprotein Metabolism. Lipids in Health and Disease, 5, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wong Chong, E., Joncas, F., Seidah, N.G., Calon, F., Diorio, C. and Gangloff, A. (2022) Circulating Levels of PCSK9, ANGPTL3 and Lp(a) in Stage III Breast Cancers. BMC Cancer, 22, Article No. 1049. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yang, H., Chen, X., Hu, W., Lv, D., Ding, W., Tang, L., et al. (2009) Lipoprotein(a) Level and Its Association with Tumor Stage in Male Patients with Primary Lung Cancer. Clinical Chemistry and Laboratory Medicine, 47, 452-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wang, F. and Zhang, Y. (2019) High Lipoprotein(a) Level Is Independently Associated with Adverse Clinicopathological Features in Patients with Prostate Cancer. Disease Markers, 2019, Article ID: 9483935. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, H., Zheng, H., Meng, P., Cao, X., Liu, J., Zhang, T., et al. (2023) Relationship between Lipoprotein(a) and Colorectal Cancer among Inpatients: A Retrospective Study. Frontiers in Oncology, 13, Article ID: 1181508. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kalaivani, V. and Jaleel, A. (2020) Apolipoprotein(a), an Enigmatic Anti-Angiogenic Glycoprotein in Human Plasma: A Curse or Cure? Pharmacological Research, 158, Article ID: 104858. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lippi, G., Franchini, M., Salvagno, G.L. and Guidi, G.C. (2007) Lipoprotein[a] and Cancer: Anti-Neoplastic Effect Besides Its Cardiovascular Potency. Cancer Treatment Reviews, 33, 427-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Bian, X., Liu, R., Meng, Y., Xing, D., Xu, D. and Lu, Z. (2020) Lipid Metabolism and Cancer. Journal of Experimental Medicine, 218, e20201606. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kamstrup, P.R. (2020) Lipoprotein(a) and Cardiovascular Disease. Clinical Chemistry, 67, 154-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Marrer, É., Wagner, A., Montaye, M., Luc, G., Amouyel, P., Dallongeville, J., et al. (2013) Lipoprotein(a) Plasma Levels and the Risk of Cancer: The PRIME Study. European Journal of Cancer Prevention, 22, 286-293. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kökoğlu, E., Karaarslan, I., Karaarslan, H.M., et al. (1994) Elevated Serum Lp(a) Levels in the Early and Advanced Stages of Breast Cancer. Cancer Biochemistry Biophysics, 14, 133-136.
|
|
[16]
|
Ioannidou, A., Watts, E.L., Perez-Cornago, A., Platz, E.A., Mills, I.G., Key, T.J., et al. (2022) The Relationship between Lipoprotein (a) and Other Lipids with Prostate Cancer Risk: A Multivariable Mendelian Randomisation Study. PLOS Medicine, 19, e1003859. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Katzke, V.A., Sookthai, D., Johnson, T., Kühn, T. and Kaaks, R. (2017) Blood Lipids and Lipoproteins in Relation to Incidence and Mortality Risks for CVD and Cancer in the Prospective EPIC-Heidelberg Cohort. BMC Medicine, 15, Article No. 218. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhang, Y., Wang, W., Xu, L., Lian, Z., Huang, J., Chang, Y., et al. (2024) Inflammation-Dependent Association of Lipoprotein (a) with Cardiovascular and Cancer Mortality. Clinical Epidemiology, 16, 1-4. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sawabe, M., Tanaka, N., Mieno, M.N., Ishikawa, S., Kayaba, K., Nakahara, K., et al. (2012) Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (the JMS Cohort Study). PLOS ONE, 7, e31954. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Schmidt, K., Noureen, A., Kronenberg, F. and Utermann, G. (2016) Structure, Function, and Genetics of Lipoprotein (a). Journal of Lipid Research, 57, 1339-1359. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yao, G., Zhang, Q., Doeppner, T.R., Niu, F., Li, Q., Yang, Y., et al. (2015) LDL Suppresses Angiogenesis through Disruption of the HIF Pathway via NF-κB Inhibition Which Is Reversed by the Proteasome Inhibitor Bsc2118. Oncotarget, 6, 30251-30262. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
McLean, J.W., Tomlinson, J.E., Kuang, W., Eaton, D.L., Chen, E.Y., Fless, G.M., et al. (1987) cDNA Sequence of Human Apolipoprotein(a) Is Homologous to Plasminogen. Nature, 330, 132-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Hancock, M.A., Boffa, M.B., Marcovina, S.M., Nesheim, M.E. and Koschinsky, M.L. (2003) Inhibition of Plasminogen Activation by Lipoprotein(a): Critical Domains in Apolipoprotein(a) and Mechanism of Inhibition on Fibrin and Degraded Fibrin Surfaces. Journal of Biological Chemistry, 278, 23260-23269. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Reyes-Soffer, G. and Westerterp, M. (2021) Beyond Lipoprotein(a) Plasma Measurements: Lipoprotein(a) and Inflammation. Pharmacological Research, 169, Article ID:105689. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Rašková, M., Lacina, L., Kejík, Z., Venhauerová, A., Skaličková, M., Kolář, M., et al. (2022) The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities. Cells, 11, Article No. 3698. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Lu, Y. and Ding, Q. (2022) Changes and Clinical Significance of Serum Lipids in Patients with Pancreatic Cancer. Jiangsu Med, 48, 109-112.
|
|
[27]
|
Ulloque-Badaracco, J.R., Al-Kassab-Córdova, A., Hernandez-Bustamante, E.A., Alarcon-Braga, E.A., Huayta-Cortez, M., Carballo-Tello, X.L., et al. (2023) Association of Apolipoproteins and Lipoprotein(a) with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Lipids in Health and Disease, 22, Article No. 98. [Google Scholar] [CrossRef]
|